MF
GOSS icon

Manchester Financial’s Gossamer Bio GOSS Stock Holding History

Manchester Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-180
Closed -$2K – 294
2021
Q1 		$2K Hold
180
– – ﹤0.01% 627
2020
Q4 		$2K Hold
180
– – ﹤0.01% 534
2020
Q3 		$2K Hold
180
– – ﹤0.01% 485
2020
Q2 		$2K Hold
180
– – ﹤0.01% 455
2020
Q1 		$2K Hold
180
– – ﹤0.01% 427
2019
Q4 		$3K Buy
+180
New +$3.63K ﹤0.01% 471

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Manchester Financial's GOSS Position: Q2 2021 in Review

Manchester Financial sold out of Gossamer Bio (GOSS) in Q2 2021, closing a stake of 180 shares — an estimated $2K sold.

Manchester Financial first reported a position in GOSS in Q4 2019 and held it in 6 quarters. The position peaked at $3K in Q4 2019. 115 funds tracked by Wall St. Rank hold GOSS as of Q2 2021.

  • Manchester Financial reported no remaining Gossamer Bio position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 180 Gossamer Bio shares in Q2 2021, an estimated $2K.
  • Manchester Financial first reported a position in Gossamer Bio in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Gossamer Bio position peaked at $3K in Q4 2019.
  • 115 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.